It comes down to pH levels, the patent authors explain.
Acidified whey protein can often taste too tart or astringent when made by conventional methods. But Glanbia Nutritionals Ireland (Brussels, Belgium) says its method, patented in late January, improves flavor, odor, tartness, and sweetness.
It comes down to pH levels, the patent authors explain. Conventional methods include dry blending an acid with whey proteins.But the pH levels of these dry-blended acidified whey proteins can only be lowered so far before significant astringency and tartness problems develop, the authors state.
Instead, Glanbia uses wet blending to first combine whey protein and an acidulant, prior to spray drying. The company uses a precise amount of acidulant to effectively lower the pH level to a desirable range (most likely between 2.8 and 5.6), subsequently improving flavor.
The process reduces the pH level just enough to improve flavor, while maintaining appropriate protein levels in a final product. “For example, in certain embodiments, substantial improvement in flavor may be obtained by reducing the pH of the whey protein composition to a value of 5.5 while still providing at least about 80 wt% [protein by weight]…” the patent authors state.
The patent authors also describe how drying the protein at a lower pH enables a more stable protein structure-which can, in turn, make the protein more resistant to the heat degradation of amino acids and the release of sulfur compounds.
The new patent, #8,637,102, is called “Acidified whey protein compositions and methods for making them.”
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine jennifer.grebow@ubm.com
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.